University of Auckland leads Covid-19 vaccine monitoring for the world

Project will coordinate monitoring of vaccines across the globe on a scale never previously seen.

GVDN team

As Covid-19 vaccines are rolled out around the world, an Auckland-headquartered research network is leading the largest-ever vaccine monitoring study.

UniServices, a wholly owned not-for-profit subsidiary of the University of Auckland, has been awarded nearly NZ$8 million (US$5.6 million) by the U.S. Centers for Disease Control and Prevention (CDC) for the study, which will be undertaken by the Global Vaccine Data Network (GVDN).

The GVDN, which has 21 partners in 17 countries, is leading an international effort to monitor and assess Covid-19 vaccines over three years.

The University of Auckland will coordinate the study, which will follow some 300 million people – a vastly larger sample than the tens of thousands involved in clinical trials.

Read More Here